Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancer.
Journal: Gynecologic oncology
Published: June 25, 2023
Impact of Sodium Thiosulfate on Prevention of Nephrotoxicities in HIPEC: An Ancillary Evaluation of Cisplatin-Induced Toxicities in Ovarian Cancer.
Journal: Annals of surgical oncology
Published: May 04, 2023
Hyperthermic Intraperitoneal Chemotherapy-Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian Cancer.
Journal: JCO precision oncology
Published: March 31, 2022
A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity.
Journal: Cancer chemotherapy and pharmacology
Published: August 30, 2018
Surgical Management of Vulvar Cancer.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: October 03, 2016
Palliative care opportunities for women with advanced ovarian cancer associated with intraperitoneal chemotherapy.
Journal: Journal of palliative medicine
Published: January 01, 2013
Toxicities, complications, and clinical encounters during intraperitoneal chemotherapy in 17 women with ovarian cancer.
Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society
Published: August 28, 2012
Showing 1-7 of 7
Last Updated: 09/26/2026